
Liked By
Spread the love. Be the first to like this post!
Recent IPSC News
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/09/2023 12:02:16 PM
- Century Therapeutics Announces Internal Portfolio Prioritization to Extend Cash Runway Into 2026 • GlobeNewswire Inc. • 01/05/2023 09:01:00 PM
- Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/04/2023 12:00:00 PM
- Century Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference • GlobeNewswire Inc. • 11/22/2022 12:00:00 PM
- Century Therapeutics Announces Presentation of Preclinical Data at the SITC 37th Annual Meeting and Provides Pipeline Updates • GlobeNewswire Inc. • 11/11/2022 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/10/2022 10:19:05 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/10/2022 12:32:52 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/10/2022 12:32:06 PM
- Century Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/10/2022 12:30:00 PM
- Century Therapeutics to Host Virtual Research and Development Day on November 11, 2022 • GlobeNewswire Inc. • 11/02/2022 11:05:00 AM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 10/11/2022 06:10:29 PM
- Century Therapeutics to Present at the SITC 37th Annual Meeting • GlobeNewswire Inc. • 10/05/2022 08:05:00 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 10/03/2022 08:09:15 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 10/03/2022 08:05:25 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 10/03/2022 11:10:02 AM
- Century Therapeutics Announces Appointment of Daphne Quimi and Timothy Walbert to its Board of Directors • GlobeNewswire Inc. • 10/03/2022 11:00:00 AM
- Century Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference • GlobeNewswire Inc. • 09/26/2022 11:00:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 09/08/2022 11:32:14 AM
- Century Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference • GlobeNewswire Inc. • 09/06/2022 11:00:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 08/25/2022 11:47:14 AM
- Century Therapeutics Receives Study May Proceed Notification from FDA for CNTY-101, the First Allogeneic Cell Therapy Product Candidate Engineered to Overcome Three Major Pathways of Host vs Graft Rejection • GlobeNewswire Inc. • 08/25/2022 11:30:00 AM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 08/11/2022 08:56:39 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 08/11/2022 12:01:24 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 08/11/2022 11:33:08 AM
- Century Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 08/11/2022 11:30:00 AM
1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition • CBDW • Jan 27, 2023 11:59 AM
IQST - iQSTEL Reminds Shareholders To Get Their Votes In Before Annual Meeting Next Week On January 31, 2023 • IQST • Jan 26, 2023 9:53 AM
Nextech AR's AI-Powered CAD to Poly Toggle3D Launches Major Technology Advancements • ARWYF • Jan 26, 2023 8:46 AM
UCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023 • UCASU • Jan 26, 2023 7:21 AM
Kaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market • KAYS • Jan 25, 2023 10:53 AM
B2 Digital's B2 SPORTS NETWORK (B2SN) Expands Distribution to Europe, Russia, and Asia with StayLIVE Agreement • BTDG • Jan 25, 2023 10:00 AM